Drug archive
Trastuzumab (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Monoclonal antibody
- antineoplastic
Description
Trastuzumab (tras-TOO-ze-mab) is a monoclonal antibody. It is used to treat breast cancer that has spread to other parts of the body. Trastuzumab may prevent the growth of some breast tumors that produce extra amounts of a certain substance known as the HER2 protein. Trastuzumab should be used only in certain patients whose breast tumors have been shown to produce extra amounts of this protein.
Trastuzumab is to be administered only by or under the immediate supervision of your doctor. It is available in the following dosage form:
- Injection (U.S.)
Brand Names
Some commonly used brand names are:
In the U.S. -
- Herceptin